Pimavanserin, a serotonin(2A) receptor inverse agonist, for the treatment of parkinson's disease psy...
Pimavanserin, a serotonin(2A) receptor inverse agonist, for the treatment of parkinson's disease psychosis
About this item
Full title
Pimavanserin, a serotonin(2A) receptor inverse agonist, for the treatment of parkinson's disease psychosis
Author / Creator
Publisher
England
Journal title
Neuropsychopharmacology (New York, N.Y.), 2010-03, Vol.35 (4), p.881
Language
English
Formats
Publication information
Publisher
England
Subjects
More information
Scope and Contents
Contents
Psychotic symptoms occur in up to 40% of patients with Parkinson's disease (PD). Clozapine and quetiapine, two atypical antipsychotic drugs, at doses markedly lower than those effective in schizophrenia, which, nevertheless, still cause sedation, hypotension, and other side effects, are widely used to treat psychotic symptoms in patients with PD ps...
Alternative Titles
Full title
Pimavanserin, a serotonin(2A) receptor inverse agonist, for the treatment of parkinson's disease psychosis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmed_primary_19907417
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_19907417
Other Identifiers
E-ISSN
1740-634X
DOI
10.1038/npp.2009.176
